- Report
- March 2024
- 110 Pages
North America
From €1337EUR$1,500USD£1,174GBP
- Report
- July 2024
- 19 Pages
Global
From €13366EUR$14,995USD£11,741GBP
- Report
- June 2025
- 70 Pages
From €3075EUR$3,450USD£2,701GBP
- Report
- December 2024
- 200 Pages
Global
From €3342EUR$3,750USD£2,936GBP
- Report
- January 2024
- 175 Pages
United States
€3387EUR$3,800USD£2,975GBP
- Report
- January 2024
- 157 Pages
United States
€3387EUR$3,800USD£2,975GBP
- Report
- January 2024
- 113 Pages
United States
€3120EUR$3,500USD£2,740GBP
- Report
- January 2024
- 37 Pages
United States
- Report
- October 2023
- 146 Pages
Global
From €3144EUR$3,528USD£2,762GBP
€3699EUR$4,150USD£3,249GBP
- Report
- January 2024
- 96 Pages
Global
From €3500EUR$4,206USD£3,182GBP
- Report
- July 2023
- 85 Pages
Global
From €3500EUR$4,206USD£3,182GBP
- Report
- July 2023
- 73 Pages
Global
From €3500EUR$4,206USD£3,182GBP
From €995EUR$1,196USD£905GBP

Psoriasis is a chronic skin condition that affects millions of people worldwide. It is characterized by red, scaly patches on the skin that can be itchy and painful. It is caused by an overactive immune system that triggers inflammation and rapid skin cell growth. Treatment for psoriasis typically involves topical medications, phototherapy, and systemic medications.
The psoriasis market is a subset of the larger dermatology market. It is a rapidly growing market, driven by the increasing prevalence of psoriasis and the development of new treatments. The market is highly competitive, with a number of companies offering treatments for psoriasis.
Some of the major companies in the psoriasis market include AbbVie, Amgen, Celgene, Janssen, Novartis, Pfizer, and UCB. These companies offer a range of treatments, including topical medications, phototherapy, and systemic medications. Show Less Read more